Implantable Cardiac Rhythm Management Device Market: Biotronik’s Strategic Shift
In late February 2025, Biotronik made headlines with a bold strategic move that redefines its role in the implantable cardiac rhythm management (CRM) device market. On February 27th, the company announced that it would be divesting its vascular intervention business to focus more intently on its portfolio of implantable solutions. This blog is originally published here: https://www.lifesciencemarketr....esearch.com/insights
Giống
Bình luận
Đăng lại
